The Global Oropharyngeal Candidiasis Market is trending towards Non-Albicans Candida Infections

 

Global Oropharyngeal Candidiasis Market

The Global Oropharyngeal Candidiasis Market involves treatment of fungal infections caused by candida species, especially Candida albicans in the throat and oral cavity. Oropharyngeal candidiasis, commonly known as oral thrush, causes white or yellow plaques in the mouth and throat. It is usually seen in older adults, infants, diabetics, and immunocompromised patients. Antifungal medications are prescribed to clear the infection and relieve symptoms. The antifungal drugs available for treating oropharyngeal candidiasis include miconazole, fluconazole, amphotericin B, nystatin, ketoconazole, voriconazole and echinocandins.

The Global Oropharyngeal Candidiasis Market is estimated to be valued at US$ 456 Mn in 2024 and is expected to exhibit a CAGR of 4.1% over the forecast period 2024 to 2031. Increased cases of candida infections due to surge in HIV prevalence and rise in diabetics and cancer patients undergoing chemotherapy has propelled market growth.

Key Takeaways

Key players operating in the Oropharyngeal Candidiasis market are Bayer AG, Teva Pharmaceuticals, Stellar Pharma, Pfizer, Wockhardt, Ranbaxy Laboratories, Bristol Laboratories, Glenmark Pharmaceuticals Ltd, and GlaxoSmithKline. Key players are focusing on drug development for effective treatment of recurrent and resistant infections.

The market is witnessing growing demand driven by rising incidence rates of opportunistic oral infections among immunocompromised patients. Moreover, increasing awareness about oral health has further boosted demand for antifungal drugs.

The market is expanding globally with presence of major pharmaceutical companies in developed regions and growth of healthcare infrastructure in developing nations.

Market Key Trends

A key trend gaining prominence in the Oropharyngeal Candidiasis Market Demand is the rise of non-albicans Candida species infections such as C. glabrata and C. krusei. Earlier, most cases of oral candidiasis were caused by C. albicans. However, with widespread use of antifungal therapies, there is emerging resistance among non-albicans species which are proving more difficult to treat than C. albicans. Drug companies are working on developing new molecules and formulations to counter resistant candida strains.

Porter's Analysis
Threat of new entrants: New pharmaceutical companies find it difficult to enter this market due to stringent regulations and the need for extensive R&D and clinical trials.

Bargaining power of buyers: Buyers have moderate bargaining power due to the availability of generic drugs and lack of product differentiation.

Bargaining power of suppliers: A few major players dominate the supply side giving them significant power in negotiations.

Threat of new substitutes: No close substitutes available due to lack of alternative therapies for oropharyngeal candidiasis.

Competitive rivalry: Intense competition among existing players to gain market share through new product launches and strategic collaborations.

Geographical Regions
North America currently holds the largest share of the global oropharyngeal candidiasis market due to growing prevalence of disease, increasing healthcare expenditure, and technologically advanced healthcare infrastructure in the region.

Asia Pacific is expected to witness the fastest growth during the forecast period owing to improving access to healthcare facilities, rising disposable incomes, and expanding medical tourism industry in developing countries such as India and China.

Get more insights on Oropharyngeal Candidiasis Market

About Author
Alice Mutum, is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.

(LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )

Comments

Post a Comment

Popular posts from this blog

Dolomite: A promising mineral for construction and agriculture industries

Image
Importance of Dolomite in construction Dolomite is one of the primary minerals used in construction industry globally. It is mainly used as an aggregate in road construction, concrete production and railway ballast. Dolomite aggregate is widely used in road construction due to its ability to withstand pressure and impact. Its high strength and durability makes it a suitable material for constructing highways, roads and bridges. Being resistant to weathering, dolomite roads last longer compared to other aggregates. Apart from aggregates, Dolomite is also used as a fluxing agent during steel manufacturing. Finely powdered dolomite is mixed with other fluxing materials in steel furnaces. The calcium-magnesium content of dolomite lowers the melting point and viscosity of slag, facilitating the steel making process. Dolomite flux also improves the fluidity and protects refractory linings of blast furnaces and basic oxygen furnaces. Another major construction application of dolomite is i...
Read more

Endocrine Therapy Drugs: The Future of Cancer Treatment

Image
Endocrine therapy drugs (ETDs) have emerged as a breakthrough in the treatment of hormone-receptor positive cancers like breast, prostate and gynecological cancers. These targeted drugs work by blocking the effects of certain hormones like estrogen and progesterone that fuel the growth of cancer cells. With continuous advancements in research, ETDs are revolutionizing cancer management and improving outcomes for millions of patients worldwide. Types of ETDs A wide range of ETDs are available today which can be broadly classified into following categories: Aromatase Inhibitors Aromatase inhibitors like anastrozole, letrozole and exemestane work by blocking the enzyme aromatase which is responsible for the formation of estrogen in tissues. By reducing estrogen levels in the body, these drugs deprive hormone receptor positive breast cancer cells of the fuel required for their growth and proliferation. They are primarily used in postmenopausal women as a treatment for hormone recept...
Read more

The Toxic Chemical Lurking in Our Daily Products: The Issue of Bisphenol A

Image
 Bisphenol A: An Overview Bisphenol A, commonly known as BPA, is a synthetic chemical that is primarily used in the production of polycarbonate plastics and epoxy resins. First developed in 1891, BPA acts as a monomer in the production of plastics and resins. These materials provide strength, durability and clarity to a wide range of products. However, over time, studies have linked BPA exposure to several health risks in both humans and animals. Prevalence in Daily Life BPA is highly prevalent in our daily lives due to its use in a variety of common consumer products and food containers. It is found in hard, clear plastic bottles for water as well as plastic containers and packaging for various canned and frozen foods. The chemical is also used in dental sealants and coatings on metal products like food cans. Even thermal paper commonly used for printing sales receipts contains BPA and leads to human exposure. The widespread use of BPA means humans are regularly exposed through ...
Read more